| 10:00 | Registration |
|---|---|
| 11:00 | Welcome |
| Session: Innovative iPSC- and MSC-derived therapeutics Chair: Roland Wagner, Technical University Braunschweig |
|
| 11:05 |
Keynote lecture: "Scalable generation of custom-made immune cells for innovative cell-based immunotherapies and industrial applications" Nico Lachmann, MHH Medizinische Hochschule Hannover |
| 11:45 |
"Process design considerations for hMSC-based products" Jan Barekzai; Florian Petry; Peter Czermak; Denise Salzig, |
| 12:05 |
Poster talk: "Biomimetic matrices enable highly defined isolation of functional mesenchymal stromal cells in xeno-/serum-free media" Kristina Thamm¹; Kristin Moebus²; Russel Towers²; Richard Wetzel¹; |
| 12:10 |
Short break |
|
Session: Therapeutic exosomes |
|
| 12:20 |
Keynote lecture: "Functional extracellular vesicles as new therapeutic modality – Exosomes’ Road to the clinic" Jens Gruber, Curexsys GmbH, Göttingen |
| 13:00 |
Poster talk: "Challenges and Solutions for Production of Therapeutic Exosomes" |
| 13:05 |
Lunch |
|
Session: New approaches in cell-based therapies |
|
| 14:00 |
Keynote lecture: "Engineering T cell receptors for adoptive cell therapy" Kilian Schober, Universitätsklinikum Erlangen |
| 14:40 |
"Cell-mediated visualization of local infections and drug delivery " Dagmar Wirth¹; Mario Köster¹; Sandhya Kumar¹; Peter Behrens²; Hansjörg Hauser¹; Andreas Kirschning³, ¹ Helmholtz Zentrum für Infektionsforschung mbH; ² Institute for Anorganic Chemistry; Leibniz University Hannover; ³ Institute for Organic Chemistry, Leibnitz University Hannover |
| 15:00 |
Keynote lecture: "Harnessing human 3D Cell Models to accelerate the development of advanced therapies" Catarina Brito, iBET & ITQB-NOVA, Oeiras/Portugal |
| 15:40 | Coffee break |
| Session: Tumor vaccines - strategies for personalisation and production Chair: Jessica Horbelt, Fraunhofer IPA, Stuttgart |
|
| 16:15 |
Keynote lecture: "Application of mRNA technology in cancer therapy" Felicitas Müller, BioNTech SE, Mainz |
| 16:55 |
"Improved production strategies for oncolytic Measles virus as therapeutic Dustin Eckhardt; Denise Salzig; Peter Czermak, Technische Hochschule Mittelhessen |
| 17:15 | End of lecture programme of day 1 |
| 17:30 - 20:00 | Get Together / Poster Session |
| Session: Clinical ATMP application and manufacturing Chair: Andrea Traube, KyooBe Tech GmbH, Leinfelden-Echterdingen |
|
| 09:00 |
Keynote lecture: "Home brewn CAR-T-Cell" Michael Schmitt, Uniklinik Heidelberg, Heidelberg |
| 09:40 |
"Running title: Modular mini-factories for the automated and scalable production of ATMPs" Andreas Traube; Jessica Horbelt; Martin Thoma; Natalie Gebken; Sarah Kleine-Wechelmann; Milena Frahm; Markus Schandar; Michael Klinger; Sebastian Puls; Rolf Wössner; Michael Pfeifer; Tobias Sauer, Fraunhofer IPA |
| 10:00 |
"Real laboratory for automated and digitalized ATMP production" Georg Popp¹; Rolf van Lengen²; Andreas Traube³; Karsten Seidl⁴; Carsten Claussen⁵; Michael Baßler⁶; Paul Franz¹; Anna Dünkel¹; Ulrike Köhl¹; Stephan Fricke¹, |
| 10:20 | Coffee break |
| Session: Innovative production strategies Chair: Anna Katharina Heide, RUHR-IP Patentanwälte, Essen |
|
| 11:00 | Keynote lecture: "Single Cell Multi-Omics Driving the Future of Adoptive Cell Therapy" Andreas Schmidt, Singleron Biotechnologies GmbH, Köln/D |
| 11:40 | "AIDPATH – Modular Manufacturing Platform for AI-enabled hospital-based ATMP Production – A Concept Presentation" Frederik Erkens, Fraunhofer Institute for Production Technology IPT |
| 12:00 | Poster talk: "Fluidic imaging as PAT tool for cell aggregate monitoring" Martin Kraft, Bayer AG |
| 12:05 |
Keynote lecture: "Tackling the Challenges of AAV Vector Manufacturing" Nicole Faust, CEVEC Pharmaceuticals GmbH, Köln |
| 12:45 | Lunch |
| Session: From regulatory framework to clinical application Chair: Hansjörg Hauser, Helmholtz Centre for Infection Research, Braunschweig |
|
| 13:30 |
"Risk Assessment – An intelligent tool for the evaluation of critical starting material" Claudia Papewalis¹; Marco Schmeer²; Martin Schleef², ¹ Valicare GmbH; |
| 13:50 |
"Plausibility of EP Patents - Post-filed experimental data as support of Anna Katharina Heide, RUHR-IP Patentanwälte, Essen |
| 14:10 |
"The current regulatory framework of ATMP storage and distribution – consequences and challenges " Andrea Zobel, World Courier |
| 14:30 | Coffee & Networking |
| 15:00 |
End of conference |
(as of 9 May 2022, subject to change)
